BAUDETTE, Minn. (AP) — BAUDETTE, Minn. (AP) — ANI Pharmaceuticals Inc. (ANIP) on Friday reported a fourth-quarter loss of $10.3 million, after reporting a profit in the same period a year earlier.
The Baudette, Minnesota-based company said it had a loss of 55 cents per share. Earnings, adjusted for one-time gains and costs, were $1.63 per share.
The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.44 per share.
The drugmaker posted revenue of $190.6 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $174.9 million.
For the year, the company reported a loss of $18.5 million, or $1.04 per share, swinging to a loss in the period. Revenue was reported as $614.4 million.
ANI expects full-year earnings in the range of $6.12 to $6.49 per share, with revenue in the range of $756 million to $776 million.
ANI shares have decreased slightly more than 1% since the beginning of the year. The stock has decreased nearly 9% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ANIP at https://www.zacks.com/ap/ANIP
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.